Magenta Therapeutics, Inc.
MGTA · NASDAQ
12/31/2024 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$84,969 | -$76,462 | -$71,136 | -$74,936 |
| Dep. & Amort. | $412 | $1,925 | $2,020 | $1,978 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $12,894 | $7,021 | $10,308 | $9,941 |
| Change in WC | $0 | -$2,702 | -$1,526 | -$1,186 |
| Other Non-Cash | -$6,517 | $3,128 | $803 | $180 |
| Operating Cash Flow | -$78,180 | -$67,090 | -$59,531 | -$64,023 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$105 | -$314 | -$1,264 | -$400 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$413,707 | -$69,498 | -$45,308 | -$95,735 |
| Inv. Sales/Matur. | $127,000 | $60,000 | $90,000 | $85,500 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$286,812 | -$9,812 | $43,428 | -$10,635 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $39,200 | $2,904 | $0 | $64,860 |
| Stock Repurch. | $0 | $115 | $141 | $104 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $255,623 | $2,878 | $89,601 | $67,739 |
| Financing Cash Flow | $255,623 | $2,878 | $89,601 | $67,739 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$109,369 | -$74,024 | $73,498 | -$6,919 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $132,391 | $133,430 | $59,932 | $66,851 |
| End Cash | $23,022 | $59,406 | $133,430 | $59,932 |
| Free Cash Flow | -$78,285 | -$67,404 | -$60,795 | -$64,423 |